{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:04:29Z","timestamp":1771265069701,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.exppara.2022.108259","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T13:01:51Z","timestamp":1649768511000},"page":"108259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A standardized intraperitoneal Glucantime\u2122 for experimental treatment of cutaneous leishmaniasis caused by Leishmania amazonensis in BALB\/c mice"],"prefix":"10.1016","volume":"236-237","author":[{"given":"Aline \u00c1vila","family":"Brustolin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nath\u00e1lia Martins","family":"Franz\u00f3i","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1quila Carolina Fernandes Herculano","family":"Ramos-Milar\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00ednthia Akemi","family":"Tanoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila Alves","family":"Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabel Galhardo","family":"Demarchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Valdrinez Campana","family":"Lonardoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tha\u00eds Gomes","family":"Verzignassi Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2022.108259_bib1","doi-asserted-by":"crossref","first-page":"105295","DOI":"10.1016\/j.ejps.2020.105295","article-title":"Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation","volume":"147","author":"Arag\u00e3o Horoiwa","year":"2020","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.exppara.2022.108259_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.16-84256","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the infectious diseases society of America (IDSA) and the American Society of tropical medicine and hygiene (ASTMH)","volume":"96","author":"Aronson","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2022.108259_bib3","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/jac\/dkm079","article-title":"A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate","volume":"59","author":"Barroso","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2022.108259_bib4","first-page":"21","article-title":"Pentavalent antimonials combined with other therapeutic alternatives for the treatment of cutaneous and mucocutaneous leishmaniasis : a systematic review","author":"Berbert","year":"2018","journal-title":"Dermatol. Res. Pract."},{"key":"10.1016\/j.exppara.2022.108259_bib5","series-title":"Manual de vigil\u00e2ncia da Leishmaniose Tegumentar","author":"Brasil","year":"2020"},{"key":"10.1016\/j.exppara.2022.108259_bib6","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/AAC.39.9.2167","article-title":"Culture microtitration : a sensitive method for quantifying Leishmania infantum in tissues of infected mice","volume":"39","author":"Buffet","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2022.108259_bib7","series-title":"Animal Extrapolation","author":"Calabrese","year":"1987"},{"key":"10.1016\/j.exppara.2022.108259_bib8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpddr.2019.06.003","article-title":"Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis","volume":"11","author":"Caridha","year":"2019","journal-title":"IJP Drugs Drug Resist."},{"key":"10.1016\/j.exppara.2022.108259_bib9","series-title":"Guia Brasileiro de Boas Pr\u00e1ticas para a Eutan\u00e1sia em Animais - Conceitos e Procediemntos Recomendados","year":"2013"},{"key":"10.1016\/j.exppara.2022.108259_bib10","unstructured":"Crist\u00e1lia Produtos Qu\u00edmicos e Farmac\u00eauticos LTDA. ANFORICINA B. Bula do Profissional de Sa\u00fade."},{"key":"10.1016\/j.exppara.2022.108259_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.exppara.2022.108259_bib12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.biopha.2017.08.096","article-title":"In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative","volume":"95","author":"de Almeida","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.exppara.2022.108259_bib13","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1007\/s00436-015-4581-1","article-title":"Activity of synthetic chalcones in hamsters experimentally infected with Leishmania (Viannia) braziliensis","volume":"114","author":"de Mello","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2022.108259_bib14","first-page":"3283","article-title":"Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by Leishmania (Viannia) braziliensis","volume":"70","author":"de Morais-Teixeira","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2022.108259_bib15","first-page":"302","article-title":"Serum creatinine : not so simple !","volume":"136","author":"Delanaye","year":"2017","journal-title":"Nephron clin. In Pract."},{"key":"10.1016\/j.exppara.2022.108259_bib16","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.parint.2012.04.006","article-title":"Effect of HIV protease inhibitors on new World Leishmania","volume":"61","author":"Demarchi","year":"2012","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.exppara.2022.108259_bib17","first-page":"1","article-title":"The arrive guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.exppara.2022.108259_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1590\/S0102-86502004000100010","article-title":"Animal disease model: choice's criteria and current animals specimens","volume":"19","author":"Fagundes","year":"2004","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.exppara.2022.108259_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.rvsc.2019.08.026","article-title":"Research in Veterinary Science Short term impacts of meglumine antimoniate treatment on kidney function in dogs with clinical leishmaniosis","volume":"126","author":"Gonz\u00e1lez","year":"2019","journal-title":"Res. Vet. Sci."},{"issue":"2","key":"10.1016\/j.exppara.2022.108259_bib20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1042\/bj0370198","article-title":"A study of the excretion of organic antimonials using a polarographic procedure","volume":"37","author":"Goodwin","year":"1942","journal-title":"Biochem. J."},{"key":"10.1016\/j.exppara.2022.108259_bib21","first-page":"119","article-title":"Effects of combined therapy with silymarin and glucantime on leishmaniasis induced by Leishmania major in BALB\/c mice","volume":"655","author":"Jabini","year":"2015","journal-title":"Drug Res."},{"key":"10.1016\/j.exppara.2022.108259_bib22","doi-asserted-by":"crossref","first-page":"108976","DOI":"10.1016\/j.vetpar.2019.108976","article-title":"Veterinary Parasitology Antileishmanial e ff ect of rapamycin as an alternative approach to control Leishmania tropica infection","volume":"276","author":"Khadir","year":"2019","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.exppara.2022.108259_bib23","first-page":"13","article-title":"The Neotropical Leishmania species: a brief historical review of their discovery, ecology and taxonomy","volume":"1","author":"Lainson","year":"2010","journal-title":"Rev. Pan-Amaz\u00f4nica Sa\u00fade"},{"key":"10.1016\/j.exppara.2022.108259_bib24","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2147\/IJN.S105952","article-title":"Polarity-sensitive nanocarrier for oral delivery of Sb(V) and treatment of cutaneous leishmaniasis","volume":"11","author":"Lanza","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.exppara.2022.108259_bib25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1369\/0022155414545787","article-title":"Picrosirius red staining: a useful tool to appraise collagen networks in normal and pathological tissues","volume":"62","author":"Lattouf","year":"2014","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.exppara.2022.108259_bib26","first-page":"5","article-title":"In vivo antileishmanial activity of Annona mucosa extracts","volume":"53","author":"de Lima","year":"2020","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.exppara.2022.108259_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1371\/journal.pntd.0003889","article-title":"A review: the current in vivo models for the discovery and utility os new anti-leishmanial drugs targeting cutaneous leishmaniasis","volume":"9","author":"Mears","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2022.108259_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.exppara.2016.07.005","article-title":"Poloxamer 407 (Pluronic\u00ae F127)-based polymeric micelles for amphotericin B: in vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis","volume":"169","author":"Mendon\u00e7a","year":"2016","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2022.108259_bib29","series-title":"Resolu\u00e7\u00e3o Normativa de Controle de Experimenta\u00e7\u00e3o Animal - Resolu\u00e7\u00e3o normativa no13, de 20 de setembro de 2013","author":"Minist\u00e9rio da Ci\u00eancia","year":"2013"},{"key":"10.1016\/j.exppara.2022.108259_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.actatropica.2007.05.005","article-title":"Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran","volume":"103","author":"Mohebali","year":"2007","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2022.108259_bib31","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s00436-019-06382-y","article-title":"In vitro and in vivo anti-parasitic activity of biogenic antimony sulfide nanoparticles on Leishmania major (MRHO\/IR\/75\/ER)","volume":"118","author":"Mohtasebi","year":"2019","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2022.108259_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exppara.2019.03.004","article-title":"The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB\/c mice","volume":"200","author":"Moosavian","year":"2019","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2022.108259_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02360-16","article-title":"Meglumine antimoniate (glucantime) causes oxidative stress-derived DNA damage in BALB\/c mice infected by Leishmania (Leishmania) infantum","volume":"61","author":"Moreira","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2022.108259_bib34","author":"Neves"},{"key":"10.1016\/j.exppara.2022.108259_bib35","article-title":"Evidence for tissue toxicity in BALB\/c exposed to a long-term treatment with oxiranes compared to meglumine antimoniate","volume":"1\u201311","author":"Oliveira","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.exppara.2022.108259_bib36","series-title":"Interactive Atlas of Leishmaniasis in the Americas: Clinical Aspects and Differential Diagnosis","year":"2020"},{"issue":"17","key":"10.1016\/j.exppara.2022.108259_bib37","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2217\/nnm-2021-0119","article-title":"In vivo efficacy of meglumine antimoniate-loaded nanoparticles for cutaneous leishmaniasis\u202f: a systematic review","volume":"16","author":"Pereira","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.exppara.2022.108259_bib38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.colsurfb.2015.12.003","article-title":"Colloids and Surfaces B : biointerfaces Topical amphotericin B in ultradeformable liposomes : formulation , skin penetration study , antifungal and antileishmanial activity in vitro","volume":"139","author":"Perez","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.exppara.2022.108259_bib39","first-page":"1","article-title":"The impact of leishmaniasis on mental health and psychosocial well-being : a systematic review","author":"Pires","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2022.108259_bib40","article-title":"Glucantime efficacy IN the treatment OF zoonotic cutaneous leishmaniasis","volume":"42","author":"Pourmohammadi","year":"2011","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"10.1016\/j.exppara.2022.108259_bib41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-4939-7113-8_26","article-title":"Method for picrosirius red-polarization detection of collagen fibers in tissue sections","volume":"1627","author":"Ritti\u00e9","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.exppara.2022.108259_bib42","series-title":"The Principles of Humane Experimental Technique","author":"Russel","year":"1959"},{"key":"10.1016\/j.exppara.2022.108259_bib43","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/026119299902700605","article-title":"The progress of humane experimental technique","volume":"27","author":"Russell","year":"1999","journal-title":"ATLA Altern. Lab. Anim."},{"key":"10.1016\/j.exppara.2022.108259_bib44","unstructured":"Sanofi-Aventis Farmac\u00eautica Ltda ., n.d. Bula Glucantime\u00ae (antimoniato de meglumina)."},{"key":"10.1016\/j.exppara.2022.108259_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3347\/kjp.2006.44.1.55","article-title":"Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB\/c mice","volume":"44","author":"Solgi","year":"2006","journal-title":"Kor. J. Parasitol."},{"key":"10.1016\/j.exppara.2022.108259_bib46","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1097\/MJT.0000000000000539","article-title":"Polycaprolactone antimony nanoparticles as drug delivery system for leishmaniasis","volume":"26","author":"de Sousa-Batista","year":"2019","journal-title":"Am. J. Therapeut."},{"key":"10.1016\/j.exppara.2022.108259_bib47","author":"World Health Organization"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489422000534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489422000534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:30:58Z","timestamp":1758004258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489422000534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":47,"alternative-id":["S0014489422000534"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2022.108259","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A standardized intraperitoneal Glucantime\u2122 for experimental treatment of cutaneous leishmaniasis caused by Leishmania amazonensis in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2022.108259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108259"}}